InspireMD
NASDAQ: NSPRMiami, US · Delaware corporation · 1 known investors
Founders & leadership
PV
Patrick VertaExecutive
PL

Pete LigottiExecutive
ML
Mike LawlessChief Financial Officer
SG

Shane GleasonExecutive
MS

Marvin SlosmanPresident and Chief Executive Officer
AT

Andrea TommasoliChief Operating Officer
AM
Alan MilinazzoExecutive
CS
Craig ShoreExecutive
JB
James BarryExecutive
Board
IB
Isaac BlechBoard director
PS
Paul StukeBoard director
RC
Raymond CohenBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$83.8M disclosed across 5 rounds · 2016–2025
▶$40.1MraisedAug 2025 · 18 investors · Other Health CareRule 506(b)
▶$40.1MraisedAug 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Raymond CohenDirector
- Thomas J. KesterDirector
- Scott R. WardDirector
- Patrick VertaExecutive Officer
- Kathryn ArnoldDirector
- Pete LigottiExecutive Officer
- Mike LawlessExecutive Officer
- Shane GleasonExecutive Officer
- Marvin SlosmanExecutive Officer, Director
- Michael BermanDirector
- Gary Roubin, M.D.Director
- Andrea TommasoliExecutive Officer
- Paul StukaDirector
- Offering amount
- $40.1M
- Amount sold
- $40.1M
- Sales commissions
- $2.4M
- Placement agents
- BofA Securities, Inc.
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$42.2MraisedMay 2023 · 18 investors · Other Health CareRule 506(b)
▶$42.2MraisedMay 2023 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Shane GleasonExecutive Officer
- Thomas J. KesterDirector
- Paul StukaDirector
- Michael BermanDirector
- Marvin SlosmanExecutive Officer, Director
- Gary Roubin, M.D.Director
- Craig ShoreExecutive Officer
- Andrea TommasoliExecutive Officer
- Kathryn ArnoldDirector
- Offering amount
- $42.2M
- Amount sold
- $42.2M
- Sales commissions
- $4.2M
- Placement agents
- Piper Sandler & Co., A.G.P./Alliance Global Partners, LifeSci Capital LLC
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedDec 2017 · 1 investors · BiotechnologyRule 506(b)
▶$750KraisedDec 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Campbell RogersDirector
- Paul StukaDirector
- Thomas KesterDirector
- James BarryExecutive Officer, Director
- Michael BermanDirector
- Craig ShoreExecutive Officer
- Offering amount
- $750K
- Amount sold
- $750K
- Minimum investment
- $750K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$182.4KraisedJun 2016 · 1 investors · BiotechnologyRule 506(b)
▶$182.4KraisedJun 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sol BarerDirector
- Campbell RogersDirector
- Isaac BlechDirector
- James BarryExecutive Officer, Director
- Craig ShoreExecutive Officer
- Paul StukeDirector
- Michael BermanDirector
- Offering amount
- $182.4K
- Amount sold
- $182.4K
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$609.5KraisedMar 2016 · 4 investors · BiotechnologyRule 506(b)
▶$609.5KraisedMar 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alan MilinazzoExecutive Officer, Director
- Michael BermanDirector
- Sol BarerDirector
- Campbell RogersDirector
- Isaac BlechDirector
- James LoughlinDirector
- Craig ShoreExecutive Officer
- Paul StukeDirector
- James BarryExecutive Officer, Director
- Offering amount
- $609.5K
- Amount sold
- $609.5K
- Sales commissions
- $48.8K
- Placement agents
- Dawson James Securities, Inc.
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapInspire Medical16 shared keywordsInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.
Simply Wall St13 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
Quiverquant12 shared keywordsQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
Companies competing with InspireMD for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are InspireMD's investors?
- InspireMD's investors include OrbiMed.
- How much funding has InspireMD raised?
- InspireMD has disclosed $83.8M raised across 5 rounds.
- Where is InspireMD headquartered?
- InspireMD is headquartered in Miami, US.

